How many insider declarations has Georgakis, Angelos filed?

Georgakis, Angelos has filed 3 public insider declarations with SEDI.

What is Georgakis, Angelos's role?

Georgakis, Angelos's reported role is not specified by the regulator across the filings.

Which companies does Georgakis, Angelos report trades for?

Georgakis, Angelos reports trades for Medicenna Therapeutics Corp..

What is Georgakis, Angelos's declared buy vs sell volume?

Across the available history, declared buys total 10k€ and disposals 0.

← Executives ★ Sign in to follow

GA

Georgakis, Angelos

OFFICER

·SEDI

Medicenna Therapeutics Corp.

0

申报总数

0

公司

€10,253

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

Discover the complete record of transactions filed by Georgakis, Angelos. Officer active across 1 company, notably Medicenna Therapeutics Corp.. In total, 3 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €10k. Activity tracked since 28 May 2026. The latest transaction was disclosed on 28 May 2026 (15 - Acquisition or disposition under a prospectus). Regulator: SEDI. All data is accessible without signup.

Companies and markets linked to Georgakis, Angelos

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Medicenna Therapeutics Corp. (CA)

申报3 总计

▲

Georgakis, Angelos

4 - Director of Issuer高管2026年5月28日Medicenna Therapeutics Corp.

CA$6,50037SEDI ↗

10,000 股@ CA$0.6539.4% 占其流量WarrantsTSXSEDI:4727150

标准退出：2026年8月26日 (T+90)

●

Georgakis, Angelos

4 - Director of Issuer高管2026年2月12日Medicenna Therapeutics Corp.

11SEDI ↗

WarrantsTSXSEDI:4727144

▲

Georgakis, Angelos

4 - Director of Issuer高管2026年5月28日Medicenna Therapeutics Corp.

CA$10,00039SEDI ↗

20,000 股@ CA$0.5060.6% 占其流量Common SharesTSXSEDI:4727141

标准退出：2026年8月26日 (T+90)

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

GA

Georgakis, Angelos

OFFICER

·SEDI

Medicenna Therapeutics Corp.

0

申报总数

0

公司

€10,253

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

Discover the complete record of transactions filed by Georgakis, Angelos. Officer active across 1 company, notably Medicenna Therapeutics Corp.. In total, 3 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €10k. Activity tracked since 28 May 2026. The latest transaction was disclosed on 28 May 2026 (15 - Acquisition or disposition under a prospectus). Regulator: SEDI. All data is accessible without signup.